3-D image of a stent inside a coronary artery taken using the Ilumien Optis

Medical devices major St Jude Medical has obtained European approval for its 3D vessel reconstruction technology, which helps in assessing the condition of arteries to treat patients with coronary artery disease (CAD).

The Ilumien Optis percutaneous coronary intervention (PCI) optimisation system is believed to aid physicians in stent placement by providing a real-time 360° panoramic view of the arteries in 3D.

With CE Mark approval in place, the company is set to display the tool in for the first time in Europe during EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Commenting on the development, Ospedale Papa Giovanni XXIII Cardiovascular Department’s Dr Giulio Guagliumi said the OCT technology is gaining significance in diagnosing and treating CAD patients.

"The Ilumien Optis system is a significant advancement in intravascular imaging technology allowing physicians to comprehensively assess more vessel in less time and more easily plan their PCI procedure," Guagliumi said.

"The three-dimensional format of the Ilumien Optis system provides a more true-to-life perspective of the arteries, which allows for individual decision making and precise guidance of stent placement to optimise coronary interventions."

St Jude Medical said that the Dragonfly Duo imaging catheter being used in the system would not only ensure near-infrared light imaging but also measure the key vessel characteristics that are difficult to assess with the present imaging methods.

With faster, longer pull-backs, the imaging catheter will allow physicians to study more of the patient’s artery without needing additional time.

The platform also integrates a wireless technology called PressureWire Aeris to measure pressure changes in blood flow and establish the severity of any narrowing or blockages within the coronary arteries leading to the heart, which helps interventional cardiologist to determine the lesions requiring stents.

St Jude Medical Cardiovascular and Ablation Technologies Division president Frank Callaghan said; "This next-generation system delivers critical information to physicians about the location and severity of disease within the coronary arteries, potentially resulting in better medical decision-making and overall cost-effective treatment."

Image: 3D image of a stent inside a coronary artery taken using the Ilumien Optis. Photo: Courtesy of St Jude Medical, Inc.